Zhang博士学术报告的通知,关于举行哈佛大学医学院张宇博士学术报告的通知

告知标题:Microphysiological Systems for Emulating Human Tissues and
Diseases报 告 人:Shrike Yu
Zhang硕士(帝国理法高校文大学布莱根妇女医务室)
间:
2018年8月30日下午15:00
点:
华北软物质科学与能力高档钻探院324报告厅材质科学与工程高校华北软物质科学与本领高端探究院2018年7月16日告知摘录:Microphysiological
systems are microfluidic three-dimensional miniature human tissue and
organ models that recapitulate the important biological and
physiological parameters of their in vivo counterparts. They have
recently emerged as a viable platform for personalized medicine and drug
screening. These biomimetic organoids are anticipated to replace the
conventional planar, static cell cultures, and to bridge the gaps
between the current pre-clinical animal models and the human body. In
addition, multiple organoids may be channeled together through the
microfluidics in a similar manner they arrange in vivo, providing the
capacity to analyze interactions among these models. In this talk, I
will discuss our recent efforts on developing integrated
multi-organ-on-a-chip platforms formed by sophisticated microfluidics
and bioengineered organoids, which can operate in a continual and
automated manner over extended periods. I will also discuss a series of
bioprinting strategies including sacrificial bioprinting, microfluidic
bioprinting, and multi-material bioprinting, along with various
cytocompatible bioink formulations, for the fabrication of biomimetic
organoids. These platform technologies will likely provide new
opportunities in constructing functional tissue and disease models with
a potential extension into clinical therapeutics and precision
therapy.报告人简单介绍:永利402com官方网站 ,Dr. Zhang received a B.Eng. in Biomedical
Engineering from Southeast University, China in 2008, after which he
then obtained a M.S. in Biomedical Engineering from Washington
University in St. Louis and a Ph.D. in Biomedical Engineering at Georgia
Institute of Technology and Emory University School of Medicine . Dr.
Zhang then pursued postdoctoral training atBrigham and Women’s
Hospital,Harvard Medical School, Harvard-MIT Division of Health Sciences
and Technologies, and Wyss Institute for Biologically Inspired
Engineering.Dr. Zhang is currently a Research Faculty at Harvard Medical
School and Associate Bioengineer at the Brigham and Women’s Hospital.
Dr. Zhang’s research is focused on innovating medical engineering
technologies, including 3D bioprinting, organs-on-chips, microfluidics,
biomedical imaging, and biosensing, to recreate functional tissues and
their biomimetic models. In collaboration with a multidisciplinary team
encompassing biomedical, mechanical, electrical, and computer engineers
as well as biologists and clinicians, his laboratory seeks to ultimately
translate these cutting-edge technologies into the clinics. He is an
author of >120 publications and his scientific contributions have
been recognized by >40 international, national, and regional awards.
More information can be found on his website (www.shrikezhang.com).

告诉标题:Microphysiological Systems for Emulating Human Tissues and
Diseases报 告 人:张宇(zhāng yǔ卡塔尔国(Y. Shrike Zhang)博士,澳大伯尔尼国立高校经济大学(Harvard
Medical School)报告时间:二零一八年10月10日深夜9:00报告地方:制浆造纸工程国家主要实验室306会议厅迎接广大师生前往!轻工业科学与工程大学二〇一八年四月十二日告诉内容:Microphysiological
systems are microfluidic three-dimensional miniature human tissue and
organ models that recapitulate the important biological and
physiological parameters of their in vivo counterparts. They have
recently emerged as a viable platform for personalized medicine and drug
screening. These biomimetic organoids are anticipated to replace the
conventional planar, static cell cultures, and to bridge the gaps
between the current pre-clinical animal models and the human body. In
addition, multiple organoids may be channeled together through the
microfluidics in a similar manner they arrange in vivo, providing the
capacity to analyze interactions among these models. In this talk, I
will discuss our recent efforts on developing integrated
multi-organ-on-a-chip platforms formed by sophisticated microfluidics
and bioengineered organoids, which can operate in a continual and
automated manner over extended periods. I will also discuss a series of
bioprinting strategies including sacrificial bioprinting, microfluidic
bioprinting, and multi-material bioprinting, along with various
cytocompatible bioink formulations, for the fabrication of biomimetic
organoids. These platform technologies will likely provide new
opportunities in constructing functional tissue and disease models with
a potential extension into clinical therapeutics and precision
therapy.报告人简单介绍:Dr. Zhang received a B.Eng. in Biomedical
Engineering from Southeast University, China in 二〇〇八, after which he
then obtained a M.S. in Biomedical Engineering from WashingtonUniversity in St. Louis and a Ph.D. in Biomedical Engineering at Georgia
Institute of Technology and Emory University School of Medicine . Dr.
Zhang then pursued postdoctoral training at Brigham and Women’s
Hospital, Harvard Medical School, Harvard-MIT Division of Health
Sciences and Technologies, and Wyss Institute for Biologically Inspired
Engineering. (www.shrikezhang.com卡塔尔国Dr. Zhang is currently a Research
Faculty at Harvard Medical School and Associate Bioengineer at the
Brigham and Women’s Hospital. His research is focused on innovating
medical engineering technologies, including 3D bioprinting,
organs-on-chips, microfluidics, biomedical imaging, and biosensing, to
recreate functional tissues and their biomimetic models. In
collaboration with a multidisciplinary team encompassing biomedical,
mechanical, electrical, and computer engineers as well as biologists and
clinicians, his laboratory seeks to ultimately translate these
cutting-edge technologies into the clinics. He is an author of >120
publications and his scientific contributions have been recognized by
>40 international, national, and regional awards. More information
can be found on his website.

相关文章